Search research articles
Contact Us
Filters
Showing results (91-100 of 172) with videos related to
Page
of 18
Sort By:
The Journal of Infection
|
April 6, 2010
The in vitro evaluation of tigecycline tested against pathogens isolated in eight countries in the Asia-Western Pacific region (2008)
David J Farrell, John D Turnidge, Jan Bell, et al.
Antimicrobial Agents and Chemotherapy
|
February 19, 2015
Activity of Debio1452, a FabI inhibitor with potent activity against Staphylococcus aureus and coagulase-negative Staphylococcus spp., including multidrug-resistant strains
Robert K Flamm, Paul R Rhomberg, Nachum Kaplan, et al.
The Journal of Antimicrobial Chemotherapy
|
June 12, 2014
Antimicrobial activity of ceftolozane/tazobactam tested against Pseudomonas aeruginosa and Enterobacteriaceae with various resistance patterns isolated in European hospitals (2011-12)
Helio S Sader, David J Farrell, Mariana Castanheira, et al.
Diagnostic Microbiology and Infectious Disease
|
July 12, 2015
Ceftazidime-avibactam activity when tested against ceftazidime-nonsusceptible Citrobacter spp., Enterobacter spp., Serratia marcescens, and Pseudomonas aeruginosa from Unites States medical centers (2011-2014)
Helio S Sader, Mariana Castanheira, David J Farrell, et al.
Journal of Clinical Microbiology
|
September 18, 2015
Determination of Disk Diffusion and MIC Quality Control Guidelines for Solithromycin, a Novel Fluoroketolide Antibacterial, against Neisseria gonorrhoeae
Stefan Riedel, James E Ross, David J Farrell, et al.
Diagnostic Microbiology and Infectious Disease
|
December 22, 2009
CEM-101, a novel fluoroketolide: antimicrobial activity against a diverse collection of Gram-positive and Gram-negative bacteria
Shannon D Putnam, Mariana Castanheira, Gary J Moet, et al.
Antimicrobial Agents and Chemotherapy
|
January 1, 2014
Antimicrobial activity of ceftazidime-avibactam against Gram-negative organisms collected from U.S. medical centers in 2012
Helio S Sader, Mariana Castanheira, Robert K Flamm, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
August 21, 2012
In vitro activity of ceftaroline against multidrug-resistant Staphylococcus aureus and Streptococcus pneumoniae: a review of published studies and the AWARE Surveillance Program (2008-2010)
David J Farrell, Mariana Castanheira, Rodrigo E Mendes, et al.
International Journal of Antimicrobial Agents
|
February 28, 2016
In vitro activity of ceftazidime/avibactam against Gram-negative pathogens isolated from pneumonia in hospitalised patients, including ventilated patients
Robert K Flamm, Wright W Nichols, Helio S Sader, et al.
Journal of Clinical Microbiology
|
May 29, 2015
Analysis of Vancomycin Susceptibility Testing Results for Presumptive Categorization of Telavancin
Rodrigo E Mendes, David J Farrell, Robert K Flamm, et al.
Page
of 18
Search research articles
Search
Showing results (91-100 of 172) with videos related to
Sort By:
Page
of 18
The Journal of Infection
|
April 6, 2010
The in vitro evaluation of tigecycline tested against pathogens isolated in eight countries in the Asia-Western Pacific region (2008)
David J Farrell, John D Turnidge, Jan Bell, et al.
Antimicrobial Agents and Chemotherapy
|
February 19, 2015
Activity of Debio1452, a FabI inhibitor with potent activity against Staphylococcus aureus and coagulase-negative Staphylococcus spp., including multidrug-resistant strains
Robert K Flamm, Paul R Rhomberg, Nachum Kaplan, et al.
The Journal of Antimicrobial Chemotherapy
|
June 12, 2014
Antimicrobial activity of ceftolozane/tazobactam tested against Pseudomonas aeruginosa and Enterobacteriaceae with various resistance patterns isolated in European hospitals (2011-12)
Helio S Sader, David J Farrell, Mariana Castanheira, et al.
Diagnostic Microbiology and Infectious Disease
|
July 12, 2015
Ceftazidime-avibactam activity when tested against ceftazidime-nonsusceptible Citrobacter spp., Enterobacter spp., Serratia marcescens, and Pseudomonas aeruginosa from Unites States medical centers (2011-2014)
Helio S Sader, Mariana Castanheira, David J Farrell, et al.
Journal of Clinical Microbiology
|
September 18, 2015
Determination of Disk Diffusion and MIC Quality Control Guidelines for Solithromycin, a Novel Fluoroketolide Antibacterial, against Neisseria gonorrhoeae
Stefan Riedel, James E Ross, David J Farrell, et al.
Diagnostic Microbiology and Infectious Disease
|
December 22, 2009
CEM-101, a novel fluoroketolide: antimicrobial activity against a diverse collection of Gram-positive and Gram-negative bacteria
Shannon D Putnam, Mariana Castanheira, Gary J Moet, et al.
Antimicrobial Agents and Chemotherapy
|
January 1, 2014
Antimicrobial activity of ceftazidime-avibactam against Gram-negative organisms collected from U.S. medical centers in 2012
Helio S Sader, Mariana Castanheira, Robert K Flamm, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
August 21, 2012
In vitro activity of ceftaroline against multidrug-resistant Staphylococcus aureus and Streptococcus pneumoniae: a review of published studies and the AWARE Surveillance Program (2008-2010)
David J Farrell, Mariana Castanheira, Rodrigo E Mendes, et al.
International Journal of Antimicrobial Agents
|
February 28, 2016
In vitro activity of ceftazidime/avibactam against Gram-negative pathogens isolated from pneumonia in hospitalised patients, including ventilated patients
Robert K Flamm, Wright W Nichols, Helio S Sader, et al.
Journal of Clinical Microbiology
|
May 29, 2015
Analysis of Vancomycin Susceptibility Testing Results for Presumptive Categorization of Telavancin
Rodrigo E Mendes, David J Farrell, Robert K Flamm, et al.
Page
of 18